A spokesperson for AstraZeneca told STAT that at this point, only the trial in the U.K. has been resumed. The company is also conducting Phase 2/3 or Phase 3 trials in the U.S. and Brazil, as well as a Phase 1/2 trial in South Africa. advertisement “The Company will continue to...
The locally dominant variant is more contagious and drove a resurgence of COVID-19 that caused nearly twice the cases, hospitalizations and deaths experienced in the initial surge of the disease in South Africa. South Africa and many other African and poor countries had looked to the Astr...
Just this week, researchers released preliminary results from a small-scale study in South Africa that found that the vaccine did little to prevent mild to moderate cases of the disease caused by the variant prevalent in the country. The study also looked solely at healthy young people. But...